Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marais

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Clinical Microbiology|June 1, 1987
Activity of sodium fusidate in vitro against anaerobic bacteriaM Robbins, R Marais, A P Wilson, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1987
The in-vitro activity of doxycycline and minocycline against anaerobic bacteriaM Robbins, R Marais, D Felmingham, et al.
European Journal of Biochemistry|June 15, 1989
Monoclonal antibodies to protein kinase C gamma. Functional relationship between epitopes and cofactor binding sitesS Cazaubon, R Marais, P Parker, et al.
The EMBO Journal|July 3, 1995
Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylationR Marais, Y Light, H F Paterson, et al.
Bioconjugate Chemistry|February 14, 1998
Gene-directed enzyme prodrug therapyI Niculescu-Duvaz, R Spooner, R Marais, et al.
Annals of the Royal College of Surgeons of England|September 24, 2020
Symptomatic hepatothorax presenting 25 years after penetrating thoracoabdominal injuryS Variawa, R Marais, Jjp Buitendag, et al.
Current Biology : CB|April 1, 1997
Phosphorylation and activation of B-Myb by cyclin A-Cdk2U Ziebold, O Bartsch, R Marais, et al.
The Journal of Experimental Medicine|March 1, 1996
Importance of low affinity Elf-1 sites in the regulation of lymphoid-specific inducible gene expressionS John, R Marais, R Child, et al.
Cancer Research|October 15, 1996
Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combinationR Marais, R A Spooner, Y Light, et al.
Cancer Gene Therapy|November 4, 2000
In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrugR A Spooner, J Martin, F Friedlos, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Clinical Microbiology|June 1, 1987
Activity of sodium fusidate in vitro against anaerobic bacteriaM Robbins, R Marais, A P Wilson, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1987
The in-vitro activity of doxycycline and minocycline against anaerobic bacteriaM Robbins, R Marais, D Felmingham, et al.
European Journal of Biochemistry|June 15, 1989
Monoclonal antibodies to protein kinase C gamma. Functional relationship between epitopes and cofactor binding sitesS Cazaubon, R Marais, P Parker, et al.
The EMBO Journal|July 3, 1995
Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylationR Marais, Y Light, H F Paterson, et al.
Bioconjugate Chemistry|February 14, 1998
Gene-directed enzyme prodrug therapyI Niculescu-Duvaz, R Spooner, R Marais, et al.
Annals of the Royal College of Surgeons of England|September 24, 2020
Symptomatic hepatothorax presenting 25 years after penetrating thoracoabdominal injuryS Variawa, R Marais, Jjp Buitendag, et al.
Current Biology : CB|April 1, 1997
Phosphorylation and activation of B-Myb by cyclin A-Cdk2U Ziebold, O Bartsch, R Marais, et al.
The Journal of Experimental Medicine|March 1, 1996
Importance of low affinity Elf-1 sites in the regulation of lymphoid-specific inducible gene expressionS John, R Marais, R Child, et al.
Cancer Research|October 15, 1996
Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combinationR Marais, R A Spooner, Y Light, et al.
Cancer Gene Therapy|November 4, 2000
In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrugR A Spooner, J Martin, F Friedlos, et al.
Pageof 7